DZ3050A1 - Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques. - Google Patents

Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques.

Info

Publication number
DZ3050A1
DZ3050A1 DZ000101A DZ000101A DZ3050A1 DZ 3050 A1 DZ3050 A1 DZ 3050A1 DZ 000101 A DZ000101 A DZ 000101A DZ 000101 A DZ000101 A DZ 000101A DZ 3050 A1 DZ3050 A1 DZ 3050A1
Authority
DZ
Algeria
Prior art keywords
octane
crystalline
pharmaceutical compositions
polymorphic forms
amine citrate
Prior art date
Application number
DZ000101A
Other languages
English (en)
French (fr)
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ3050A1 publication Critical patent/DZ3050A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ000101A 1999-06-01 2000-05-31 Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques. DZ3050A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
DZ3050A1 true DZ3050A1 (fr) 2004-03-27

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000101A DZ3050A1 (fr) 1999-06-01 2000-05-31 Formes polymorphes d'un citrate d'azobicydoÄ2,2,2Ü-octane-3-amine cristallin et leurs compositions pharmaceutiques.

Country Status (48)

Country Link
US (1) US6255320B1 (cs)
EP (1) EP1181290B1 (cs)
JP (1) JP3830816B2 (cs)
KR (1) KR100476606B1 (cs)
CN (1) CN1146565C (cs)
AP (1) AP2001002349A0 (cs)
AR (1) AR033331A1 (cs)
AT (1) ATE244239T1 (cs)
AU (1) AU767334B2 (cs)
BG (1) BG65240B1 (cs)
BR (1) BR0011094A (cs)
CA (1) CA2372238C (cs)
CO (1) CO5170463A1 (cs)
CY (1) CY2007011I1 (cs)
CZ (1) CZ295819B6 (cs)
DE (1) DE60003679T2 (cs)
DK (1) DK1181290T3 (cs)
DZ (1) DZ3050A1 (cs)
EA (1) EA003731B1 (cs)
EC (1) ECSP003508A (cs)
EE (1) EE200100656A (cs)
ES (1) ES2199825T3 (cs)
GT (1) GT200000087A (cs)
HN (1) HN2000000077A (cs)
HR (1) HRP20010904A2 (cs)
HU (1) HUP0201301A3 (cs)
IL (1) IL146406A0 (cs)
MA (1) MA26742A1 (cs)
MX (1) MXPA01012325A (cs)
MY (1) MY133508A (cs)
NO (1) NO20015848L (cs)
NZ (1) NZ515349A (cs)
OA (1) OA11956A (cs)
PA (1) PA8496101A1 (cs)
PE (1) PE20010209A1 (cs)
PL (1) PL196046B1 (cs)
PT (1) PT1181290E (cs)
SI (1) SI1181290T1 (cs)
SK (1) SK285820B6 (cs)
SV (1) SV2001000093A (cs)
TN (1) TNSN00120A1 (cs)
TR (1) TR200103473T2 (cs)
TW (1) TWI285204B (cs)
UA (1) UA66925C2 (cs)
UY (1) UY26176A1 (cs)
WO (1) WO2000073304A1 (cs)
YU (1) YU81101A (cs)
ZA (1) ZA200109775B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070129328A1 (en) * 2004-01-30 2007-06-07 BOETTNER Wayne Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
CA2554823A1 (en) * 2004-01-30 2005-09-09 Pfizer Products Inc. Nk-1 receptor antagonists to improve anesthesia recovery
US8183230B2 (en) * 2004-01-30 2012-05-22 Pfizer Inc. Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
US20090099364A1 (en) * 2004-02-02 2009-04-16 Pfizer Inc. Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
AU2014228414B2 (en) * 2013-03-15 2018-09-13 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639B (zh) * 2019-12-16 2025-08-08 凯默斯医药科技(上海)有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2084361T3 (es) * 1991-05-31 1996-05-01 Pfizer Derivados de quinuclidina.
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
CZ295819B6 (cs) 2005-11-16
BG106204A (en) 2002-07-31
BG65240B1 (bg) 2007-09-28
MXPA01012325A (es) 2002-07-22
PE20010209A1 (es) 2001-03-01
TNSN00120A1 (fr) 2005-11-10
PT1181290E (pt) 2003-09-30
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
JP3830816B2 (ja) 2006-10-11
IL146406A0 (en) 2002-07-25
CA2372238A1 (en) 2000-12-07
HK1046284A1 (en) 2003-01-03
YU81101A (sh) 2004-07-15
GT200000087A (es) 2001-11-22
OA11956A (en) 2006-04-13
DK1181290T3 (da) 2003-09-29
TR200103473T2 (tr) 2002-04-22
MA26742A1 (fr) 2004-12-20
EP1181290B1 (en) 2003-07-02
CY2007011I2 (el) 2010-07-28
JP2003501354A (ja) 2003-01-14
SK285820B6 (sk) 2007-09-06
DE60003679T2 (de) 2004-05-27
CN1146565C (zh) 2004-04-21
CA2372238C (en) 2006-12-19
AU4424800A (en) 2000-12-18
CZ20014269A3 (cs) 2002-04-17
HUP0201301A3 (en) 2002-10-28
EA200101108A1 (ru) 2002-04-25
EA003731B1 (ru) 2003-08-28
CO5170463A1 (es) 2002-06-27
PL352716A1 (en) 2003-09-08
BR0011094A (pt) 2002-03-19
SK17332001A3 (sk) 2002-07-02
ECSP003508A (es) 2002-02-25
ATE244239T1 (de) 2003-07-15
HRP20010904A2 (en) 2003-02-28
KR20020010688A (ko) 2002-02-04
AR033331A1 (es) 2003-12-17
HUP0201301A2 (en) 2002-08-28
ES2199825T3 (es) 2004-03-01
AU767334B2 (en) 2003-11-06
HN2000000077A (es) 2001-02-02
NO20015848D0 (no) 2001-11-30
AP2001002349A0 (en) 2001-12-31
MY133508A (en) 2007-11-30
KR100476606B1 (ko) 2005-03-18
DE60003679D1 (de) 2003-08-07
ZA200109775B (en) 2002-11-28
NZ515349A (en) 2004-03-26
EP1181290A1 (en) 2002-02-27
CY2007011I1 (el) 2010-07-28
PL196046B1 (pl) 2007-11-30
UY26176A1 (es) 2000-12-29
TWI285204B (en) 2007-08-11
SV2001000093A (es) 2001-11-08
UA66925C2 (uk) 2004-06-15
PA8496101A1 (es) 2002-07-30
SI1181290T1 (en) 2003-12-31
CN1353711A (zh) 2002-06-12
WO2000073304A1 (en) 2000-12-07
EE200100656A (et) 2003-02-17

Similar Documents

Publication Publication Date Title
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
MA26673A1 (fr) Composes pharmaceutiques
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
MA26816A1 (fr) Derives d'amino-triazolopyridine
NO20015175L (no) Farmasöytisk sammensetning
ID26743A (id) Turunan 1,2,4,5-tetrahidro-benzo [d] azepin
FR2761265B1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
FR2761266B1 (fr) Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
PT1242087E (pt) Composicoes farmaceuticas
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
DK1095932T3 (da) Phenoxyeddikesyrederivat og pharmaceutiske sammensætninger omfattende den samme
NO20015670L (no) Forbedrede farmasöytiske formuleringer
NO20002686L (no) Forbedring av Peyronies sykdom
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
DK1200118T3 (da) En farmaceutisk sammensætning omfattende megalatran og dens prodrug
CY2007011I1 (el) Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους
FR2792529B1 (fr) Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
FR2833842B1 (fr) Compositions pharmaceutiques a base de derives d'azetidine
PT1239832E (pt) Composicoes farmaceuticas
DK1227817T3 (da) Ciclesonid-holdigt vandigt farmaceutisk præparat
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
PT102384A (pt) Composicoes farmaceuticas compreendendo metanossulfonato de paroxentina
FR2797444B1 (fr) Compositions pharmaceutiques comprenant des 4-quinolones